Cholesteryl Ester Transfer Protein Inhibition Enhances Endothelial Repair and Improves Endothelial Function in the Rabbit

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 3, 2015, Pages 628-636

  Wu, Ben J ^a,c,d   Shrestha, Sudichhya ^a,d   Ong, Kwok L ^a,c,d   Johns, Douglas ^b   Hou, Liming ^a,d   Barter, Philip J ^a,c,d   Rye, Kerry Anne ^a,c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b MERCK RESEARCH LABORATORIES   (United States)

^c University of Sydney   (Australia)

^d HEART RESEARCH INSTITUTE   (Australia)

Author keywords

cholesteryl ester transfer protein; endothelium; inhibition; lipoproteins, HDL

Indexed keywords

ACETYLCHOLINE; ANACETRAPIB; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PDZ PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE B; SCAVENGER RECEPTOR BI; CARRIER PROTEIN; HYPOCHOLESTEROLEMIC AGENT; OXAZOLIDINONE DERIVATIVE; PDZK1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 4,5-BIPHOSPHATE KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE INHIBITOR; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ENDOTHELIUM; AORTA INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE REPAIR; VASCULAR RING; ABDOMINAL AORTA; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL CULTURE; CELL MOTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HYPERPLASIA; INJURIES; MALE; METABOLISM; NEOINTIMA; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; REGENERATION; RNA INTERFERENCE; TIME FACTOR; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SYSTEM INJURIES; VASODILATATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA, ABDOMINAL; APOLIPOPROTEIN A-I; CARRIER PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERPLASIA; MALE; NEOINTIMA; OXAZOLIDINONES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; REGENERATION; RNA INTERFERENCE; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION; VASCULAR SYSTEM INJURIES; VASODILATION; VASODILATOR AGENTS;

EID: 84922214306     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304747     Document Type: Article

References (40)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 79 8 15
2. Khera AV, Rader DJ, Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep 2010 12 73 81. doi: 10.1007/s11883-009-0080-0
3. Nicholls SJ, Dusting GJ, Cutri B, Bao S, Drummond GR, Rye KA, Barter PJ, Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 2005 111 1543 1550. doi: 10.1161/01.CIR.0000159351.95399.50
4. Tabet F, Lambert G, Cuesta Torres LF, Hou L, Sotirchos I, Touyz RM, Jenkins AJ, Barter PJ, Rye KA, Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages. Arterioscler Thromb Vasc Biol 2011 31 1192 1200. doi: 10.1161/ATVBAHA.110.222000
5. Zerrad-Saadi A, Therond P, Chantepie S, Couturier M, Rye KA, Chapman MJ, Kontush A, HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 2009 29 2169 2175. doi: 10.1161/ATVBAHA.109.194555
6. Mineo C, Deguchi H, Griffin JH, Shaul PW, Endothelial and antithrombotic actions of HDL. Circ Res 2006 98 1352 1364. doi: 10.1161/01.RES.0000225982.01988.93
7. Tso C, Martinic G, Fan WH, Rogers C, Rye KA, Barter PJ, High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 2006 26 1144 1149. doi: 10.1161/01.ATV.0000216600.37436.cf
8. Spieker LE, Sudano I, Hürlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Lüscher TF, Noll G, High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002 105 1399 1402
9. Sumi M, Sata M, Miura S, Rye KA, Toya N, Kanaoka Y, Yanaga K, Ohki T, Saku K, Nagai R, Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2007 27 813 818. doi: 10.1161/01.ATV.0000259299.38843.64
10. Fryirs MA, Barter PJ, Appavoo M, Tuch BE, Tabet F, Heather AK, Rye KA, Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 2010 30 1642 1648. doi: 10.1161/ATVBAHA.110.207373
11. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ, High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995 15 1987 1994
12. Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ, Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res 1999 40 345 353
13. McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK, Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 2009 29 877 882. doi: 10.1161/ATVBAHA.109.184663
14. Puranik R, Bao S, Nobecourt E, Nicholls SJ, Dusting GJ, Barter PJ, Celermajer DS, Rye KA, Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis 2008 196 240 247. doi: 10.1016/j.atherosclerosis.2007.05.008
15. Wu BJ, Chen K, Shrestha S, Ong KL, Barter PJ, Rye KA, High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1. Circ Res 2013 112 278 288. doi: 10.1161/CIRCRESAHA.111.300104
16. Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ, Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 2005 25 2416 2421. doi: 10.1161/01.ATV.0000184760.95957.d6
17. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR, Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003 23 160 167
18. Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J, Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008 299 2777 2788. doi: 10.1001/jama.299.23.2777
19. Voight BF, Peloso GM, Orho-Melander M, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012 380 572 580. doi: 10.1016/S0140-6736(12)60312-2
20. Johannsen TH, Frikke-Schmidt R, Schou J, Nordestgaard BG, Tybjærg-Hansen A, Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects. J Am Coll Cardiol 2012 60 2041 2048. doi: 10.1016/j.jacc.2012.07.045
21. Zhang B, Fan P, Shimoji E, Xu H, Takeuchi K, Bian C, Saku K, Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits. Arterioscler Thromb Vasc Biol 2004 24 1910 1915. doi: 10.1161/01.ATV.0000143389.00252.bc
22. Okamoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, Shinkai H, A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 2000 406 203 207. doi: 10.1038/35018119
23. Huang Z, Inazu A, Nohara A, Higashikata T, Mabuchi H, Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia. Clin Sci (Lond) 2002 103 587 594
24. Morehouse LA, Sugarman ED, Bourassa PA, Sand TM, Zimetti F, Gao F, Rothblat GH, Milici AJ, Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits. J Lipid Res 2007 48 1263 1272. doi: 10.1194/jlr.M600332-JLR200
25. Barter PJ, Caulfield M, Eriksson M, ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007 357 2109 2122. doi: 10.1056/NEJMoa0706628
26. Schwartz GG, Olsson AG, Abt M, dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012 367 2089 2099. doi: 10.1056/NEJMoa1206797
27. Hime NJ, Drew KJ, Wee K, Barter PJ, Rye KA, Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. J Lipid Res 2006 47 115 122. doi: 10.1194/jlr.M500284-JLR200
28. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, Stocker R, Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 2006 203 1117 1127. doi: 10.1084/jem.20052321
29. Wu BJ, Midwinter RG, Cassano C, Beck K, Wang Y, Changsiri D, Gamble JR, Stocker R, Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009 29 1537 1542. doi: 10.1161/ATVBAHA.109.184713
30. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL, Rader DJ, Shaul PW, High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006 98 63 72. doi: 10.1161/01.RES.0000199272.59432.5b
31. Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C, The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 2008 102 480 487. doi: 10.1161/CIRCRESAHA.107.159079
32. Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ, Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 2004 350 1505 1515. doi: 10.1056/NEJMoa031766
33. Radojkovic C, Genoux A, Pons V, Combes G, de Jonge H, Champagne E, Rolland C, Perret B, Collet X, Tercé F, Martinez LO, Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation. Arterioscler Thromb Vasc Biol 2009 29 1125 1130. doi: 10.1161/ATVBAHA.109.187997
34. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR, ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010 328 1689 1693. doi: 10.1126/science.1189731
35. Mineo C, Yuhanna IS, Quon MJ, Shaul PW, High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 2003 278 9142 9149. doi: 10.1074/jbc.M211394200
36. Zhang Q, Zhang Y, Feng H, Guo R, Jin L, Wan R, Wang L, Chen C, Li S, High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells. PLoS One 2011 6 e23556. doi: 10.1371/journal.pone.0023556
37. Pellegatta F, Bragheri M, Grigore L, Raselli S, Maggi FM, Brambilla C, Reduzzi A, Pirillo A, Norata GD, Catapano AL, In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels. Int J Mol Med 2006 17 203 208
38. Vaisman BL, Lambert G, Amar M, Joyce C, Ito T, Shamburek RD, Cain WJ, Fruchart-Najib J, Neufeld ED, Remaley AT, Brewer HB Jr, Santamarina-Fojo S, ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001 108 303 309. doi: 10.1172/JCI12517
39. Feng Y, Lievens J, Jacobs F, Hoekstra M, Van Craeyveld E, Gordts SC, Snoeys J, De Geest B, Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis. Cardiovasc Res 2010 88 376 385. doi: 10.1093/cvr/cvq204
40. Huang CY, Lin FY, Shih CM, Au HK, Chang YJ, Nakagami H, Morishita R, Chang NC, Shyu KG, Chen JW, Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways. Arterioscler Thromb Vasc Biol 2012 32 2405 2417. doi: 10.1161/ATVBAHA.112.248617